October 2023
1. CHEN J, Huang L, Zeng L, Jiang Z, et al
   The reference range of lamotrigine in the treatment of epilepsy in children: a systematic review.
   Eur J Clin Pharmacol. 2023 Oct 31. doi: 10.1007/s00228-023-03562.
   

   >> Share

   
   August 2023
2. WEI S, Li X, Zhang Q, Wu H, et al
   Population pharmacokinetics of topiramate in Chinese children with epilepsy.
   Eur J Clin Pharmacol. 2023 Aug 19. doi: 10.1007/s00228-023-03549.
   

   >> Share

   
   June 2023
3. BOZINA N, Sporis IS, Domjanovic IK, Ganoci L, et al
   Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy.
   Eur J Clin Pharmacol. 2023 Jun 20. doi: 10.1007/s00228-023-03526.
   

   >> Share

   
   August 2022
4. YAO N, Huang S, Huang A, Song H, et al
   Analysis of influencing factors on monohydroxylated derivative of oxcarbazepine plasma concentration in children with epilepsy.
   Eur J Clin Pharmacol. 2022 Aug 25. pii: 10.1007/s00228-022-03373.
   

   >> Share

   
   January 2022
5. YARYARI AM, Mazdeh M, Mohammadi M, Haghi AR, et al
   Evaluation of serum levels of asprosin and other metabolic profiles in patients with idiopathic tonic-clonic generalized epilepsy on treatment with valproic acid.
   Eur J Clin Pharmacol. 2022 Jan 20. pii: 10.1007/s00228-022-03279.
   

   >> Share

   
   August 2020
6. YOON HY, Ahn MH, Yee J, Lee N, et al
   Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis.
   Eur J Clin Pharmacol. 2020;76:1053-1058.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share